Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Syros Pharmaceuticals, Inc. (SYRS) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/20/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
04/20/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
10/11/2022 4/A Chee Conley (Chief Commercial Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 44,500 options to buy @ $6.73, valued at $299.5k
Granted 34,000 restricted stock units @ $0
02/10/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
12/21/2020 4/A Quirk Gerald E (Chief Legal & Admin. Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 35,000 options to buy @ $13.3, valued at $465.5k
09/22/2017 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
09/22/2017 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
09/22/2017 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
09/22/2017 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
09/22/2017 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
09/22/2017 4/A Nashat Amir (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 11,000 options to buy @ $0
09/22/2017 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
09/22/2017 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy